Infographic: The Impact of ERP With Pharmaceutical Companies

Streamlined processes across multiple business units, efficient and centralized data management, and excellent informatics to support fast and informed decision making are all essential for ensuring sponsors can move drug candidates quickly and safely through clinical trials on the path to commercialization. The use of enterprise resource planning (ERP) software among pharmaceutical and related companies is a critical part of this journey. ERP drives efficiency in multiple business areas—particularly for companies undergoing equity events.

To better understand how sponsors are using ERP software in their businesses today and its impact, Pharmaceutical Executive in partnership with Sikich conducted a survey of the PharmExec audience about drivers of growth, the current use of business systems, main areas of software use, and the expectations of ERP software. The infographic below presents some of the top findings.

Pharmaceutical ERP infographic

For a more detailed analysis of the findings, download the full report and check out our blog series that showcase the most interesting survey findings. These posts include commentary from some of our experts, who have helped over 175 life sciences companies deploy ERP, built specifically for their industry.

Blog Posts in this Series

This publication contains general information only and Sikich is not, by means of this publication, rendering accounting, business, financial, investment, legal, tax, or any other professional advice or services. This publication is not a substitute for such professional advice or services, nor should you use it as a basis for any decision, action or omission that may affect you or your business. Before making any decision, taking any action or omitting an action that may affect you or your business, you should consult a qualified professional advisor. In addition, this publication may contain certain content generated by an artificial intelligence (AI) language model. You acknowledge that Sikich shall not be responsible for any loss sustained by you or any person who relies on this publication.

About the Author